Stericycle (SRCL) Price Target Raised to $75.00 at Royal Bank of Canada

Stericycle (NASDAQ:SRCL) had its price target hoisted by investment analysts at Royal Bank of Canada to $75.00 in a research report issued to clients and investors on Friday, The Fly reports. The firm currently has an “underperform” rating on the business services provider’s stock. Royal Bank of Canada’s price objective would suggest a potential upside of 4.17% from the company’s current price.

Several other analysts have also recently issued reports on SRCL. Zacks Investment Research cut shares of Stericycle from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. Jefferies Group set a $108.00 price target on shares of Stericycle and gave the stock a “buy” rating in a research report on Tuesday, October 17th. Stifel Nicolaus reissued a “buy” rating and set a $85.00 price target (down previously from $95.00) on shares of Stericycle in a research report on Thursday, November 9th. BMO Capital Markets reduced their price target on shares of Stericycle from $74.00 to $62.00 and set a “market perform” rating on the stock in a research report on Friday, November 10th. Finally, Barrington Research reduced their price target on shares of Stericycle from $87.00 to $75.00 and set an “outperform” rating on the stock in a research report on Friday, November 10th. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company. Stericycle currently has a consensus rating of “Hold” and a consensus price target of $75.18.

Stericycle (NASDAQ SRCL) opened at $72.00 on Friday. Stericycle has a 1 year low of $61.25 and a 1 year high of $88.00. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.82 and a quick ratio of 0.82. The company has a market cap of $6,190.00, a PE ratio of -128.57, a price-to-earnings-growth ratio of 1.74 and a beta of 0.16.

Stericycle (NASDAQ:SRCL) last posted its earnings results on Wednesday, November 8th. The business services provider reported $1.10 EPS for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.04). The company had revenue of $883.00 million during the quarter, compared to analyst estimates of $896.81 million. Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The company’s quarterly revenue was down .8% compared to the same quarter last year. During the same period in the previous year, the company earned $1.24 EPS. equities research analysts forecast that Stericycle will post 4.49 EPS for the current fiscal year.

In related news, Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $67.43, for a total transaction of $1,331,944.79. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders have sold 79,012 shares of company stock worth $5,240,668 over the last 90 days. Insiders own 3.50% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the stock. NEXT Financial Group Inc increased its stake in shares of Stericycle by 77.9% during the third quarter. NEXT Financial Group Inc now owns 2,322 shares of the business services provider’s stock worth $164,000 after buying an additional 1,017 shares during the period. ARGI Investment Services LLC purchased a new stake in shares of Stericycle during the third quarter worth approximately $215,000. Zions Bancorporation purchased a new stake in shares of Stericycle during the third quarter worth approximately $233,000. Cadence Capital Management LLC purchased a new stake in shares of Stericycle during the third quarter worth approximately $234,000. Finally, Zeke Capital Advisors LLC purchased a new stake in shares of Stericycle during the third quarter worth approximately $250,000. Hedge funds and other institutional investors own 94.49% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Stericycle (SRCL) Price Target Raised to $75.00 at Royal Bank of Canada” was first posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3148699/stericycle-srcl-price-target-raised-to-75-00-at-royal-bank-of-canada.html.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

The Fly

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.